121 related articles for article (PubMed ID: 36410105)
1. Multi-omics inference of differential breast cancer-related transcriptional regulatory network gene hubs between young Black and White patients.
Aguilar B; Abdilleh K; Acquaah-Mensah GK
Cancer Genet; 2023 Jan; 270-271():1-11. PubMed ID: 36410105
[TBL] [Abstract][Full Text] [Related]
2. Enhanced immortalization,
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene X; 2020 Dec; 5():100030. PubMed ID: 32550556
[TBL] [Abstract][Full Text] [Related]
3. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
[TBL] [Abstract][Full Text] [Related]
4. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
Kim I; Choi S; Kim S
BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data.
Hua Y; Gao L; Li X
Pathol Oncol Res; 2021; 27():1609789. PubMed ID: 34408553
[No Abstract] [Full Text] [Related]
8. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer.
Xie D; Chen Y; Wan X; Li J; Pei Q; Luo Y; Liu J; Ye T
Front Endocrinol (Lausanne); 2022; 13():916469. PubMed ID: 35784532
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
[TBL] [Abstract][Full Text] [Related]
10. Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
Gong Z; Chen J; Wang J; Liu S; Ambrosone CB; Higgins MJ
PLoS One; 2021; 16(3):e0249229. PubMed ID: 33784351
[TBL] [Abstract][Full Text] [Related]
11. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
12. Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma.
Goeppert B; Ernst C; Baer C; Roessler S; Renner M; Mehrabi A; Hafezi M; Pathil A; Warth A; Stenzinger A; Weichert W; Bähr M; Will R; Schirmacher P; Plass C; Weichenhan D
Epigenetics; 2016 Nov; 11(11):780-790. PubMed ID: 27593557
[TBL] [Abstract][Full Text] [Related]
13. Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations.
Cortes-Urrea C; Bueno-Gutiérrez F; Solarte M; Guevara-Burbano M; Tobar-Tosse F; Vélez-Varela PE; Bonilla JC; Barreto G; Velasco-Medina J; Moreno PA; Rivas JL
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365829
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.
Akhoondi S; Lindström L; Widschwendter M; Corcoran M; Bergh J; Spruck C; Grandér D; Sangfelt O
Breast Cancer Res; 2010; 12(6):R105. PubMed ID: 21122106
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers.
Sivadas A; Kok VC; Ng KL
Breast Cancer Res Treat; 2022 Jun; 193(2):361-379. PubMed ID: 35348974
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
17. Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
Stewart PA; Luks J; Roycik MD; Sang QX; Zhang J
PLoS One; 2013; 8(12):e82460. PubMed ID: 24324792
[TBL] [Abstract][Full Text] [Related]
18. Towards
Batten DJ; Crofts JJ; Chuzhanova N
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761935
[TBL] [Abstract][Full Text] [Related]
19. Multi-omics integration analysis of GPCRs in pan-cancer to uncover inter-omics relationships and potential driver genes.
Li S; Chen X; Chen J; Wu B; Liu J; Guo Y; Li M; Pu X
Comput Biol Med; 2023 Jul; 161():106988. PubMed ID: 37201441
[TBL] [Abstract][Full Text] [Related]
20. A workflow to study mechanistic indicators for driver gene prediction with Moonlight.
Nourbakhsh M; Saksager A; Tom N; Chen XS; Colaprico A; Olsen C; Tiberti M; Papaleo E
Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37551622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]